March 14, 2018 / 10:53 AM / 6 months ago

BRIEF-Hikma Pharmaceuticals CFO Says Expects 2018 Revenue In Range Of $1.85-$2 Bln

March 14 (Reuters) - Hikma Pharmaceuticals Plc:

* HIKMA PHARMACEUTICALS CFO SAYS EXPECTS 2018 REVENUE IN THE RANGE OF $1.85 BILLION TO CLOSE TO $2 BILLION ‍​

* HIKMA PHARMACEUTICALS EXECUTIVE CHAIRMAN SAYS EXPECTS HIGH LEVEL OF PRICE EROSION IN U.S. GENERICS MARKET TO CONTINUE INTO 2018‍​

* HIKMA PHARMACEUTICALS CFO SAYS EXPECTS 2018 CAPITAL EXPENDITURE IN THE RANGE OF $120 MILLION TO $140 MILLION

* HIKMA PHARMACEUTICALS CFO SAYS CONSOLIDATATION OF MANUFACTURING OPERATIONS IN U.S WOULD RESULT IN ANOTHER 200 JOB CUTS Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below